Ethnic and racial differences in long-term survival from hospitalization for HIV infection

Journal of Health Care for the Poor and Underserved

Volumn 11, Issue 2, 2000, Pages 163-178

  Cunningham, William E ^a,b   Mosen, David M ^c   Morales, Leo S ^a   Andersen, Ronald M ^a   Shapiro, Martin F ^a   Hays, Ron D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

Access to care; AIDS; Ethnicity; HIV; Race; Survival

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HISPANIC; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORTALITY; PROSPECTIVE STUDY;

ADULT; AFRICAN AMERICANS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; MALE; PATIENT ADMISSION; PROSPECTIVE STUDIES;

EID: 0034181584     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.2010.0709     Document Type: Article

References (55)

1. Rothenberg R, Woelfel M, Stoneburner R, et al. Survival with the acquired immunodeficiency syndrome: Experience with 5,833 cases in New York City. N Engl J Med 1987;317:1297-1302.
2. Lemp GF, Payne SF, Neal D, et al. Survival trends for patients with AIDS. JAMA 1990; 263(3):402-6.
3. Menendez BS, Drucker E, Vermund SH, et al. AIDS mortality among Puerto Ricans and other Hispanics in New York City, 1981-1987. J AIDS 1990;3(6):644-48.
4. Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991;324(20):1412-16.
5. Desenclos JC, Hahn RA. Years of potential life lost before age 65, by race, Hispanic origin, and sex - US, 1986-1988. MMWR CDC Surveil Summ 1992;41(6):13-23.
6. Bennett CL, Horner RD, Weinstein RA, et al. Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med 1995;155:1586-92.
7. Selik RM, Chu SY. Years of potential life lost due to HIV infection in the United States. AIDS 1997;11:1635-39.
8. Curtis RJ, Patrick DL. Race and survival time with AIDS: A synthesis of the literature. Am J Public Health 1993;83(10):1425-28.
9. Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by Hispanic status in the United States. JAMA 1993;270(20):2464-68.
10. Elo IT, Preston SH. Racial and ethnic differences in mortality at older ages. In: Martin LG, Soldo BJ, eds. Racial and ethnic differences in health. Washington, DC: National Research Council, 1997.
11. Valdez RB, Giachello A, Rodriguez-Trias H, et al. Improving access to health care in Latino communities. Public Health Rep 1993;108(5):534-39.
12. Cunningham WE, Hays RD, Williams KW, et al. Access to medical care and health-related quality of life for low income, symptomatic, HIV-infected individuals. Med Care 1995;33(7):1-16.
13. Cunningham WE, Hays RD, Ettl MK, et al. The prospective effect of access to medical care on health-related quality of life outcomes in patients with symptomatic HIV disease. Med Care 1998;36(3):295-306.
14. Brown ER. Data watch: Trends in health insurance coverage in California, 1989-1993. Health Affairs 1996;15(1):118-30.
15. Diaz T, Chu SY, Conti L, et al. Health insurance coverage among persons with AIDS: Results from a multistate surveillance project. Am J Public Health 1994;84(6):1015-18.
16. Klevens RM, Diaz T, Fleming PL, et al. Trends in AIDS among Hispanics in the United States, 1991-1996. Am J Public Health 1999;89(7):1104.
17. California Department of Health Services, Office of AIDS. California HIV partner counseling and referral service program. California HIV/AIDS Update 1998;11(3).
18. California Department of Health Services, Office of AIDS. AIDS among racial/ethnic groups in California, 1998. Sacramento, CA: California Department of Health Services, Office of AIDS, 1999.
19. Diaz T, Buehler JW, Castro KG, Ward JW. AIDS trends among Hispanics in the United States. Am J Public Health 1993;83(4):504-10.
20. Ginzberg E. Access to health care for Hispanics. JAMA 1991;265(2):238-41.
21. Woloshin S, Bickell NA, Schwartz LM, et al. Language barriers in medicine in the United States. JAMA 1995;273(9):724-28.
22. Schur CL, Albers LA. Language, sociodemographics, and health care use of Hispanic adults. J Health Care Poor Underserved 1996;7(2):140-58.
23. Andersen R, Lewis SZ, Giachello AL, et al. Access to medical care among the Hispanic population of the southwestern United States. J Health Soc Behav 1981;22(1):78-89.
24. California Department of Health Services, Office of AIDS. First 100,000 AIDS cases - California, through April 1997. California HIV/AIDS Update 1997;10:42.
25. Center for Health Economics and Policy. Health status among Hispanics: Major themes and new priorities. JAMA 1991;265(2):255-57.
26. Centers for Disease Control and Prevention. Update: Trends in AIDS incidence, deaths and prevalence-United States, 1996. MMWR 1997;46(8):165-73.
27. Cunningham WE, Hays RD, Mosen DM, et al. Access to community-based medical services and number of hospitalizations among patients with HIV disease: Are they related? J AIDS 1996;13(4):341-49.
28. Ettl MK, Hays RD, Cunningham WE, Shapiro MF. Assessing health related quality of life in disadvantaged HIV-infected populations. In: Spilker B, ed. Quality of life and pharmacal economics in clinical trials (2nd ed.). New York: Lippincott-Raven, 1995
29. Cunningham WE, Bozzette SA, Hays RD, et al. Comparison of health-related quality of life among clinical trial and non-clinical trial HIV-infected cohorts. Med Care 1995;33(4):AS15-AS25.
30. Freeman HE. National survey of access to health. Princeton, NJ: Robert Wood Johnson Foundation, 1986.
31. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989;320(21):1388-93.
32. Turner BJ, Kelly JV, Ball JK. A severity classification system for AIDS hospitalizations. Med Care 1989;27(4):423-37.
33. Mosen DM. Survival time among hospitalized persons with HIV disease: Does access to medical care matter? PhD dissertation, Department of Health Services, UCLA School of Public Health, 1997.
34. Easterbrook PJ, Keruly JC, Creagh-Kirk T, et al. Racial and ethnic differences in outcomes in Zidovudine-treated patients with advanced HTV disease. JAMA 1991;266(19):2713-18.
35. Estrada A, Trevino L, Fernando M, Ray LA. Health care utilization barriers among Mexican Americans: Evidence from HHANES1982-84. Am J Public Health 1990;80(suppl.):27-31.
36. Katz MH, Bindman AB, Komaromy MS. Coping with HIV infection: Why people delay care. Ann Intern Med 1992;117(9):797.
37. Katz MH, Bindman AB, Keane D, Chan AK. CD4 lymphocyte counts as indicator of delay in seeking human immunodeficiency virus-related treatment. Arch Intern Med 1992;152:1501-4
38. Mosen DM, Wenger NS, Shapiro MF, et al. Is access to medical care associated with receipt of HIV testing and counseling? AIDS Care 1998;10(5):617-28.
39. Hubbell FA, Waitzkin H, Mishra S, et al. Access to medical care for documented and undocumented Latinos in a Southern California county. West J Med 1991;154(4):414-17.
40. Asch S, Leake B, Gelberg L. Does fear of immigration authorities deter tuberculosis patients from seeking care? West J Med 1994;161(4):373-76.
41. Morales LS, Cunningham WE, Brown JA, et al. Are Latinos less satisfied with communication from health care providers? J Gen Internal Med 1999;14(7):409-17.
42. Baker DW, Parker RM, Williams MV, et al. Use and effectiveness of interpreters in an emergency department. JAMA 1996;275(10):783-88.
43. Thomson GE. Discrimination in health care. Ann Intern Med 1997;126(11):910-12.
44. Palella FJ, Delaney KM, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
45. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2905-15.
46. Andersen R, Bozzette S, Shapiro M, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the U.S. Health Services Res 2000.
47. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279(6):450-54.
48. Hellinger FJ, Fleishman JA, Hsia DC. AIDS treatment costs during the last months of life: Evidence from the ACSUS. Health Services Res 1994;29(5):569-81.
49. Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994;330(11):763-68.
50. Stein MD, Piette J, Mor V, et al. Differences in access to Zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med 1991;6:35-40.
51. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. JAMA 1997;277(24):1962-69.
52. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998;280(1):78-86.
53. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: The end of opportunism? JAMA 1998;280:72-77.
54. Shapiro MF, Morton SC, McCaffrey DF, et al. HIV/AIDS care in the United States II: Variations in receipt of care: Initial results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2905-15.
55. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: Examples from the AIDS literature. Ann Intern Med 1996;124(11):999-1005.